NanoVibronix, Inc.

Equities

NAOV

US63008J6038

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Other stock markets 16:30:00 2024-05-20 EDT			5-day change	1st Jan Change
0.7201 ^USD	-4.84%		+0.01%	-37.38%

05-14	NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield	MT
05-14	NanoVibronix, Inc. Announces Distribution Agreement with Cb Medical, Llc for the Distribution of Uroshield	CI

NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award

May 01, 2024 at 08:00 am

NanoVibronix, Inc. announced that effective May 1, 2024, the Company?s PainShield product will be included in the U.S. Department of Veteran Affairs? Federal Supply Schedule, a program that supports the healthcare acquisition needs of the VA and other government agencies. Delta Medical, LLC, a service-disabled veteran-owned small business and distributor of the Company?s PainShield product, was awarded a five-year FSS contract by the VA, that includes the Company?s PainShield product.

Latest news about NanoVibronix, Inc.

NanoVibronix Signs Multiyear Distribution Deal With CB Medical for UroShield	05-14	MT
NanoVibronix, Inc. Announces Distribution Agreement with Cb Medical, Llc for the Distribution of Uroshield	05-14	CI
NanoVibronix Announces PainShield Will Be Included in Department of Veteran Affairs? FSS Contract Award	05-01	CI
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	04-08	CI
NanoVibronix, Inc. Enters into Letter of Intent with APOGEPHA Arzneimittel GmbH to Explore European Distribution Opportunity	12-04	CI
NanoVibronix, Inc. Signs Research Agreement for Clinical Study of UroShield with University of Michigan	11-28	CI
NanoVibronix, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	11-13	CI
Investors Eye Fed Moves as US Futures Trend Lower in Friday's Premarket	23-10-20	MT
NanoVibronix, Inc. Gains Approval for Inclusion of UroShield Products in NHS Prescription Services' Drug Tariff	23-09-27	CI
NanoVibronix Files Registration Statement on Behalf of Selling Shareholders	23-09-13	MT
NanoVibronix to Raise $5 Million Through Securities Placement	23-08-30	MT
Top Midday Gainers	23-08-30	MT
NanoVibronix, Inc. announced that it expects to receive $5 million in funding	23-08-29	CI
NanoVibronix Says It's Working to Understand Implications of CMS Decision Related to PainShield Device	23-08-29	MT
NanoVibronix, Inc. Applies for Inclusion of Uroshield Products in Nhs Prescription Services' Drug Tariff	23-08-28	CI
NanoVibronix Extends Distribution Agreement With Ultra Pain Products for Ultrasound Therapy Devices; Shares Rise	23-08-23	MT
NanoVibronix Extends Distribution Agreement with Its Largest Distributor for PainShield and PainShield Plus	23-08-23	CI
NanoVibronix, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	23-08-11	CI
NanoVibronix Announces Distribution Agreement with Mio-Guard	23-06-14	CI
NanoVibronix, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023	23-05-15	CI
NanoVibronix, Inc. Reports Earnings Results for the Full Year Ended December 31, 2022	23-04-17	CI
NanoVibronix, Inc. Receives Positive Final Results of Independent Lifecycle Testing of PainShield Prompted by Centers for Medicare and Medicaid Services	23-03-28	CI
NanoVibronix Files Provisional Patent Application in US for UroShield Ultra; Shares Jump	23-03-21	MT
NanoVibronix, Inc. Files Provisional U.S. Patent Application for UroShield Ultra	23-03-21	CI
Nanovibronix, Inc. Announces Positive Results from Independent Product Trial of UroShield for Patients with A Spinal Cord Injury	23-03-14	CI

Chart NanoVibronix, Inc.

Duration

Period

More charts

Company Profile

NanoVibronix, Inc. is a medical device company. The Company develops medical devices utilizing its patented low intensity surface acoustic wave technology. Its products include UroShield and PainShield. UroShield is an ultrasound-based product that is designed to prevent bacterial colonization and biofilm in urinary catheters, increase antibiotic efficacy and decrease pain and discomfort associated with urinary catheter use. UroShield Ultra is similar to UroShield, but is designed to prevent bacterial colonization and biofilm formation in urinary catheters. PainShield is a patch-based therapeutic ultrasound technology to treat pain, muscle spasm and joint contractures by delivering a localized ultrasound effect to treat pain and induce soft tissue healing in a targeted area. Its PainShield family of products includes PainShield MD, PainShield Plus and WoundShield. WoundShield is a patch-based therapeutic ultrasound device intended to facilitate tissue regeneration and wound healing.

Sector

Medical Equipment, Supplies & Distribution

More about the company

Income Statement Evolution

More financial data

Sector Other Medical Equipment, Supplies & Distribution

	1st Jan change	Capi.
NANOVIBRONIX, INC.	-37.38%	2.11M
ABBOTT LABORATORIES	-6.23%	181B
MEDTRONIC PLC	+2.59%	114B
BECTON, DICKINSON AND COMPANY	-2.75%	68.29B
DEXCOM, INC.	+5.32%	52.24B
CENCORA, INC.	+7.61%	44.3B
HOYA CORPORATION	+6.67%	42.73B
METTLER-TOLEDO INTERNATIONAL, INC.	+25.17%	32.52B
TERUMO CORPORATION	+20.03%	26.02B
WEST PHARMACEUTICAL SERVICES, INC.	-2.66%	25.91B

Other Medical Equipment, Supplies & Distribution